Arrowhead Pharma Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
| | | |

Arrowhead Pharma Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)

On Nov. 18, 2025, Arrowhead Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved REDEMPLO…

Cartoon Illustrating “The NIH and U.S. Healthcare in Crisis” Published
| | | | | | | | | | | | | | | | | | | | | | | | |

Cartoon Illustrating “The NIH and U.S. Healthcare in Crisis” Published

On Apr. 21, 2025, LifeScienceHistory.com published the cartoon: “The National Institutes of Health (NIH) and U.S. Healthcare in…

The Women in Scholarship, Engineering, Science & Technology began at the University of Alberta
| | | | | | | | | | |

The Women in Scholarship, Engineering, Science & Technology began at the University of Alberta

In 1982, the WISEST (Women in Scholarship, Engineering, Science & Technology) began at the University of Alberta when…